© 2020 MJH Life Sciences and OncLive. All rights reserved.
June 23, 2020
February 20, 2020
Jason J. Luke, MD, FACP, discusses predictive biomarkers in metastatic melanoma.
January 07, 2020
Jason J. Luke, MD, FACP, discusses current and emerging treatment paradigms in metastatic melanoma.
July 29, 2015
At the 2015 ASCO Annual Meeting, we witnessed an extraordinary explosion into the general oncology consciousness of the Programmed Death-1: Programmed Death Ligand-1 axis and drugs that target that interaction.